Mylan shares fall on EpiPen pricing

In this video

Share

Mylan shares fall on EpiPen pricing

The "FMHR" traders and Stephanie Link, TIAA Global Asset Management, discuss Mylan's EpiPen pricing saga and whether it's a new catalyst to sell Biotech.
04:05
Tue, Aug 23 201612:45 PM EDT